Insigneo Advisory Services LLC decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 58.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,443 shares of the exchange traded fund’s stock after selling 3,377 shares during the quarter. Insigneo Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $228,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. ICA Group Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $27,000. Scarborough Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $32,000. ORG Partners LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $40,000. Vima LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $45,000. Finally, Resources Management Corp CT ADV lifted its holdings in SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares in the last quarter.
SPDR S&P Biotech ETF Stock Performance
NYSEARCA:XBI opened at $98.43 on Friday. The stock’s fifty day moving average price is $98.94 and its two-hundred day moving average price is $93.97. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The company has a market cap of $7.50 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- What is an Earnings Surprise?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- The Significance of Brokerage Rankings in Stock Selection
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.